InsidersTradesSigma
MapLight Therapeutics, Inc. Stock: price and management transactions · United States · SEC (Form 4)
Follow the MapLight Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €449.1m. The latest transaction was filed on 28 July 2026 (Acquisition). Among the most active insiders: GILLIS JONATHAN. All data is accessible without an account.
120
Insider Decl.
n/a
Thresholds
€500,149
3 ops.
Buy Volume
€14m
75 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate MapLight Therapeutics, Inc. Strong Buy (bullish), based on 13 analysts. Average price target: US$43.85.
50Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 July 2026
Declarations120 total
6,979 shares@ US$36.660.015% mcap6.6% of flowVoting Common StockSEC:0001709954-26-000010:2
200 shares@ US$38.390.0004% mcap0.2% of flowVoting Common StockSEC:0002021238-26-000010:6
5,356 shares@ US$36.130.011% mcap5.0% of flowVoting Common StockSEC:0001709954-26-000010:0
4,699 shares@ US$36.940.010% mcap4.5% of flowVoting Common StockSEC:0001709954-26-000010:1
1,476 shares@ US$37.440.0032% mcap1.4% of flowVoting Common StockSEC:0001709954-26-000010:3
600 shares@ US$36.510.0013% mcap0.6% of flowVoting Common StockSEC:0001709954-26-000010:4
16,969 shares@ US$37.610.037% mcap16.4% of flowVoting Common StockSEC:0001709954-26-000010:5
900 shares@ US$38.170.0020% mcap0.9% of flowVoting Common StockSEC:0001709954-26-000010:6
5,545 shares@ US$36.130.012% mcap5.8% of flowVoting Common StockSEC:0002021238-26-000010:0
4,510 shares@ US$36.940.0097% mcap4.8% of flowVoting Common StockSEC:0002021238-26-000010:1
7,464 shares@ US$36.660.016% mcap7.9% of flowVoting Common StockSEC:0002021238-26-000010:2
1,592 shares@ US$37.440.0035% mcap1.7% of flowVoting Common StockSEC:0002021238-26-000010:3
2,833 shares@ US$37.050.0061% mcap3.0% of flowVoting Common StockSEC:0002021238-26-000010:4
14,140 shares@ US$37.700.031% mcap15.3% of flowVoting Common StockSEC:0002021238-26-000010:5
17,173 shares@ US$37.220.037% mcap100.0% of flowCommonSEC144:0001950047-26-007189
18,469 shares@ US$37.220.040% mcap100.0% of flowCommonSEC144:0001950047-26-007188
5,103 shares@ US$36.990.011% mcap10.9% of flowVoting Common StockSEC:0001789970-26-000012:1
11 shares@ US$37.960.0000% mcap0.0% of flowVoting Common StockSEC:0001789970-26-000012:5
8,972 shares@ US$36.990.019% mcap7.5% of flowVoting Common StockSEC:0002021233-26-000012:3
3,656 shares@ US$37.900.0081% mcap3.1% of flowVoting Common StockSEC:0002021233-26-000012:8
4,776 shares@ US$36.450.010% mcap10.0% of flowVoting Common StockSEC:0001789970-26-000012:3
5,009 shares@ US$36.450.011% mcap8.0% of flowVoting Common StockSEC:0001728746-26-000012:3
12 shares@ US$37.960.0000% mcap0.0% of flowVoting Common StockSEC:0001728746-26-000012:5
7,155 shares@ US$36.160.015% mcap5.9% of flowVoting Common StockSEC:0002021233-26-000012:0
25 of 120 declarations
关于 MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. 是一家专注于开发神经系统疾病创新疗法的公司。该公司在纳斯达克上市，股票代码为 XNAS。